Impact of Bevacizumab on parenchymal damage and functional recovery of the liver in patients with colorectal liver metastases.

BMC Cancer · 2016 · PMC4750178 · PMID 26864935

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

just failed to reach statistical significancep = 0.08so close (0.05 < p ≤ 0.1)

The reduced incidence of posthepatectomy liver failure in patients with bevacizumab treatment just failed to reach statistical significance (0.61 [0.34, 1.07]; p = 0.08 I 2 = 6 %).

also in 203 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.